Studies performed by us and others indicate that CLL cells are characterized by increased expression of the p27Kip1 protein, also known as cyclin-dependent kinase inhibitor 1B (CDKN1B) [26,27,28,29,30]. The gene discussed is CDKN1B; the disease is B-cell chronic lymphocytic leukemia.